^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CT0180
i
Other names: CT0180, GPC3 CAR-T, glypican-3 (GPC3) directed CAR-T cell therapy, CSG-GPC3, Glypican 3 chimeric antigen receptor T cell therapy, KJgpc3-001, CAR-GPC3 T Cells, chimeric antigen receptor T cells targeting glypican-3, GPC3-CAR/CSG-GPC3, GPC3-CAR-T cell therapy, anti-GPC3 CAR T
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
CARsgen
Drug class:
GPC-3-targeted CAR-T immunotherapy
Related drugs:
